摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-tert-butoxycarbonyl-L-leucyl-L-methioninamide | 2280-68-4

中文名称
——
中文别名
——
英文名称
N-tert-butoxycarbonyl-L-leucyl-L-methioninamide
英文别名
(S,S)-N-(tert-butoxycarbonyl)leucylmethionine amide;Boc-LeuΨ(CH2NH)Met-NH2;BOC-L Leu-L Met-NH2;BOC-Leu-Met-NH2;Boc-L-Leu-methionamid;tert-butyl N-[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamate
N-tert-butoxycarbonyl-L-leucyl-L-methioninamide化学式
CAS
2280-68-4
化学式
C16H31N3O4S
mdl
——
分子量
361.506
InChiKey
OJANTFFQNUJOQL-RYUDHWBXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    24
  • 可旋转键数:
    11
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.81
  • 拓扑面积:
    136
  • 氢给体数:
    3
  • 氢受体数:
    5

SDS

SDS:f0c02507fb2b1ed206a6658b25352e25
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Activity of the C-terminal part of substance P on guinea pig ileum and trachea preparations I. N-acylated pentapeptides SP(7–11)
    摘要:
    DOI:
    10.1016/0223-5234(88)90006-2
  • 作为产物:
    描述:
    Boc-L-蛋氨酸N-甲基吗啉 、 sodium hydroxide 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 2.0h, 生成 N-tert-butoxycarbonyl-L-leucyl-L-methioninamide
    参考文献:
    名称:
    人组织蛋白酶F与二肽腈抑制剂的活性位点图。
    摘要:
    恒定链的切割是主要组织相容性复合体II类的运输途径中的关键事件。组织蛋白酶S是恒定链的主要加工酶,但是组织蛋白酶F在巨噬细胞中作为其功能增效剂起作用,其在恒定链切割中与组织蛋白酶S一样有效。尚未开发出针对组织蛋白酶F的专用低分子量抑制剂。用52个二肽腈作为共价可逆抑制剂进行反应,绘制了一个活性位点图,以绘制人组织蛋白酶F非引物结合区的结构-活性关系。在逐步过程中,设计了具有优化片段组合的新化合物,并合成的。在人半胱氨酸组织蛋白酶F,B,L,K和S上评估了这些二肽腈。化合物10(ñ - (4-苯基苯甲酰基)-leucylglycine腈)和12(ñ - (4-苯基苯甲酰基)leucylmethionine腈)被认为是人类的有效抑制剂的组织蛋白酶F,其ķ我值<10N的中号。利用我们研究中的所有二肽腈,生成了3D活动图,以可视化此系列组织蛋白酶F抑制剂的结构与活性之间的关系。
    DOI:
    10.1002/cmdc.201500151
点击查看最新优质反应信息

文献信息

  • Palladium-catalyzed reaction of tributyltin hydride. Selective and very mild deprotection of allyl and allyloxycarbonyl derivatives of amino-acids.
    作者:F Guibe、O Dangles、G Balavoine
    DOI:10.1016/s0040-4039(00)84530-x
    日期:——
    Allyl(All) and Allyloxycarbonyl(Alloc) amino-acid derivatives are deprotected through palladium-catalyzed hydrostannolysis by Bu3SnH in a highly selective manner. Benzyl and benzyloxycarbonyl groups are stable under these conditions. Moreover the allyl and Alloc groups seem orthogonal to the t-butyl and t-butoxycarbonyl protecting groups.
    烯丙基(All)和烯丙氧基羰基(Alloc)氨基酸衍生物通过Bu 3 SnH以高选择性的方式通过钯催化的氢化锡烷基水解进行脱保护。苄基和苄氧羰基在这些条件下是稳定的。此外,烯丙基和Alloc基团似乎与叔丁基和叔丁氧羰基保护基团正交。
  • Optimum Cross-linking Spacer Length of Dimeric Neurokinin B Analogs for Interaction with NK-1 Tachykinin Receptors.
    作者:Hiroshi Matsumoto、Yasuyuki Shimohigashi、Yukio Takano、Kazuyasu Sakaguchi、Hiro-o Kamiya、Motonori Ohno
    DOI:10.1246/bcsj.66.196
    日期:——
    A series of dimeric analogs of neurokinin B (NKB) COOH-terminal heptapeptide were synthesized in order to find an optimum length of cross-linking spacer for bivalent interaction with tachykinin receptors. Dimerization was carried out at the NH2-terminus of heptapeptide with succinyl bis[(Gly)n–OH], in which the number of glycine varies from 0 to 4. Dimers D–(Gly)n–NKB4—10, namely succinyl bis[(Gly)n–Asp–Ser–Phe–Val–Gly–Leu–Met–NH2] (n = 0—4), were almost inactive in the assay using rat vas deferens, indicating that they have no interaction with NK-2 receptor subtype. In contrast, these dimers were very active in guinea pig ileum (GPI) containing all of NK-1, 2, and 3 receptors. Relative activity was highest when the cross-linking spacer with oligoglycine of n = 2, and decreased sharply for dimers with shorter and longer chain lengths (n = 0 and 1; 3 and 4). In order to specify receptor subtype (NK-1 or NK-3) in GPI to which dimers bind, dimers were examined under the conditions that NK-1 receptors are desensitized by substance P methyl ester. All dimers exhibited drastically diminished contractile activity, indicating that dimers exclusively interact with NK-1. This was further confirmed by blocking the response of NK-3 receptors with atropine, which had no effect on the contractile activity of dimers. The results suggested that dimers interact bivalently with NK-1 receptors by bridging adjacent two binding sites.
    为寻找与速激肽受体二价相互作用的最佳连接间隔长度,合成了一系列神经激肽B(NKB)羧基端七肽的二聚体类似物。通过琥珀酰双[甘氨酸(n)—OH]在七肽的氨基端进行二聚化,其中甘氨酸的数目从0到4变化。二聚体D–(甘氨酸)n–NKB4—10,即琥珀酰双[甘氨酸(n)–天冬氨酸–丝氨酸–苯丙氨酸–缬氨酸–甘氨酸–亮氨酸–蛋氨酸–NH2](n = 0—4),在利用大鼠输精管进行的实验中几乎无活性,表明它们与NK-2受体亚型无相互作用。相比之下,这些二聚体在含有所有NK-1、NK-2和NK-3受体的大鼠回肠(GPI)中非常活跃。当连接间隔为n = 2的寡甘氨酸时,相对活性最高,而链长更短和更长的二聚体(n = 0和1;3和4)活性显著降低。为了明确二聚体在GPI中结合的受体亚型(NK-1或NK-3),在NK-1受体被甲酯化的P物质脱敏的条件下检测了二聚体。所有二聚体的收缩活性都急剧降低,表明二聚体专门与NK-1受体相互作用。进一步通过利用阿托品阻断NK-3受体的反应,证实了这一点,阿托品对二聚体的收缩活性没有影响。结果表明,二聚体通过桥接相邻的两个结合位点与NK-1受体发生二价相互作用。
  • Synthesis and Biological Evaluation of Dehydrophenylalanine Containing Substance P Fragments
    作者:Paramjeet Kaur、Gyanedra Kumar Patnaik、Ram Raghubir、Virander Singh Chauhan
    DOI:10.1246/bcsj.65.3412
    日期:1992.12
    Peptide fragments of Substance P corresponding to the C-terminal segments (6-11) and (4-11), which contain a putative β-turn, were synthesised using solution phase methodology. Analogs of Substance P were synthesised where the phenylalanine residue at position 8 was replaced by dehydrophenylalanine (ΔPhe) and the glycine residue in position 9 was replaced by alanine, valine, sarcosine (N–Me–Gly) and α-aminoisobutyric acid. In two of the analogs [8-ΔPhe, 9-Sar]–SP (4-11) (5) and [5,8-ΔPhe, 9-Aib]–SP (4-11) (7) glutamine residue at position 5 was also substituted by ΔPhe. These analogs were evaluated for their ability to cause smooth muscle contraction in guinea pig ileum preparation (in vitro) and for hypotensive activity (in vivo) in female rats anesthetized with urethane. In the hexapeptide series [8-ΔPhe]–SP (6-11) (1) and [8-ΔPhe, 9-Sar]–SP (6-11) (4) showed significant activity in both the assays. Octapeptide [5,8-ΔPhe, 9-Sar]–SP (4-11) (5) with ΔPhe residue in positions 5 and 8 and sarcosine in position 9 was found to be the most potent analog both in vitro and in vivo systems.
    合成了与物质P的C端片段(6-11)和(4-11)相对应的肽段,这些片段包含一个假定的β-转角,采用溶液相的方法。合成了物质P的类似物,其中第8位的苯丙氨酸残基被脱氢苯丙氨酸(ΔPhe)替代,第9位的甘氨酸残基被丙氨酸、缬氨酸、肌氨酸(N–Me–Gly)和α-氨基异丁酸替代。在两个类似物[8-ΔPhe, 9-Sar]–SP (4-11) (5)和[5,8-ΔPhe, 9-Aib]–SP (4-11) (7)中,第5位的谷氨酰胺残基也被ΔPhe替代。这些类似物在豚鼠回肠制备中(体外)评估了其引起平滑肌收缩的能力,并在以氨基甲酸酯麻醉的雌性大鼠中评估了其降血压活性。在六肽系列中,[8-ΔPhe]–SP (6-11) (1)和[8-ΔPhe, 9-Sar]–SP (6-11) (4)在两项实验中均显示出显著的活性。八肽[5,8-ΔPhe, 9-Sar]–SP (4-11) (5)在第5和第8位具有ΔPhe残基并在第9位含有肌氨酸,发现其在体外和体内系统中是最有效的类似物。
  • Synthesis and biological activity of substance P C-terminal hexapeptide analogues: structure-activity studies
    作者:Constantine Poulos、John R. Brown、Christopher C. Jordan
    DOI:10.1021/jm00157a028
    日期:1986.7
    series of analogues of the C-terminal hexapeptide of substance P, modified at the glutaminyl residue, was synthesized and their relative activities as spasmogens were determined in the guinea pig ileum and rat colon muscularis mucosae preparations in vitro. In general, when compared to SP6-11, the loss of the carboxamide group has little effect on activity in the colon and reduces activity on the ileum
    合成了一系列在谷氨酰胺残基上修饰的物质P的C端六肽类似物,并在体外确定了豚鼠回肠和大鼠结肠粘膜黏膜制剂中作为痉挛源的相对活性。通常,与SP6-11相比,羧酰胺基的丢失对结肠的活性影响很小,而对回肠的活性降低。例外的是Orn6类似物,它在两种制剂中均具有活性,被提议作为结构活性研究的有用工具。结论是6位取代基的氢键电势可能是生物活性的重要决定因素。
  • Studies on peptides. CXIV. Synthesis of hylambates-kassinin, a frog skin tachykinin peptide.
    作者:NOBUTAKA FUJII、SHINICHI KATAKURA、HARUAKI YAJIMA、YOSHIHIRO NAKATA、ATSUKO INOUE、TOMIRO SEGAWA
    DOI:10.1248/cpb.31.4259
    日期:——
    Hylambates-kassinin, a new amphibian skin dodecapeptide of the tachykinin family, was synthesized in a conventional manner using thioanisole-mediated deprotection with trifluoromethanesulfonic acid. The contractile potency of synthetic hylambates-kassinin in isolated guinea-pig duodenum was 1.4 times higher than that of synthetic kassinin.
    Hylambates-kassinin是一种新的两栖动物皮肤十二肽,属于速激肽家族。它采用传统方法合成,使用了以硫醚为介质的去保护反应,辅以三氟甲烷磺酸。合成的Hylambates-kassinin在孤立的豚鼠十二指肠中的收缩效力是合成的kassinin的1.4倍。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物